Axinn Represents Berkshire Partners in the Antitrust Aspects of its Acquisition of Forcura and Medalogix
March 19, 2025
Axinn successfully represented Berkshire Partners in the antitrust aspects of the parallel acquisitions of two post-acute care software companies: Forcura, an intelligent workflow management company; and Medalogix, a clinical decision support company. Together, the two complementary companies create a leading healthcare technology platform that brings real efficiencies and improved patient care, starting with home-based healthcare and expanding across the broader healthcare industry. Berkshire is the majority owner of the combined company.
The team was led by partners John Harkrider and Craig Minerva along with associates Laviana Alharmoosh, Josh Jowdy, and Megan Dill. The deal closed on March 19, 2025.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
ABA White Collar Crime Institute 2026
Speaking Engagement
GCR Live Cartels: 2026
Speaking Engagement
Antitrust
Noerr Competition Day 2026
Speaking Engagement
Antitrust
Consumer Brands CPG Legal Forum 2026
Speaking Engagement
NBA CLS 39th Annual Corporate Counsel Conference
Sponsorship
Antitrust
University of Pennsylvania Journal of Business Law Annual Symposium 2026
Speaking Engagement
Antitrust
2025 Healthcare Antitrust Enforcement Wrap Up
Axinn Viewpoints
Antitrust
Here We Go Again: Third Round of Inflation Reduction Act Drugs Listed
Axinn Viewpoints
Intellectual Property
CLA Antitrust and Consumer Protection Section In-House Counsel Summit
Speaking Engagement
Antitrust
New Frontiers of Antitrust – 16th Annual International Conference of Concurrences Review
Speaking Engagement
Antitrust